Pharmaceuticals, Biotechnology and Life Sciences
Realm Therapeutics has won FDA’s approval for its IND application to proceed with Phase II clinical trial for atopic dermatitis (AD) drug.
Janssen Biotech is looking to expand the usage of its prescription drug Stelara, as it has asked the U.S. Food…
U.S. Food and Drug Administration (FDA) has approved Pfizer’s Eucrisa (crisaborole) ointment 2%, a novel non-steroidal topical phosphodieterase-4 (PDE-4) inhibitor…
Sanofi and Regeneron Pharmaceuticals have announced that the European Medicines Agency (EMA) has accepted for review the Marketing Authorization Application…
LEO Pharma and MorphoSys AG have entered into a strategic alliance for the discovery and development of therapeutic antibodies for the treatment…